Peutz-Jeghers syndrome screening: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, [[mammography]], and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome. | Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, [[mammography]], and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome. | ||
==Screening== | ==Screening== | ||
Patients who are at risk of developing Peutz-Jeghers syndrome are | Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by: | ||
*[[Esophagogastroduodenoscopy| | *[[Esophagogastroduodenoscopy|Upper GI endoscopy]] | ||
*[[Enteroclysis]] | *[[Enteroclysis]] | ||
*[[Colonoscopy]] | *[[Colonoscopy]] | ||
Screening for cancerous lesions among patients with Peutz-Jeghers syndrome include the following: | |||
Screening for cancerous lesions include the following: | |||
*Small intestine radiography (every 2 years) | *Small intestine radiography (every 2 years) | ||
*[[Esophagogastroduodenoscopy]] (every 2 years) | *[[Esophagogastroduodenoscopy]] (every 2 years) |
Revision as of 18:53, 9 September 2015
Peutz-Jeghers syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Peutz-Jeghers syndrome screening On the Web |
American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening |
Risk calculators and risk factors for Peutz-Jeghers syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou (Pap) test are recommended among patients with Peutz-Jeghers syndrome.
Screening
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:
Screening for cancerous lesions among patients with Peutz-Jeghers syndrome include the following:
- Small intestine radiography (every 2 years)
- Esophagogastroduodenoscopy (every 2 years)
- Colonoscopy every 2 years
- Pancreatic ultrasound (annually)
- Endoscopic ultrasound
- Magnetic resonance cholangiopancreatography (MRCP)
- Abdominal CT
- Pelvic ultrasound (annually)
- Testicular ultrasound (annually)
- Mammography at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually
- Cervical Papanicolaou (Pap) test (annually).
- Annual physical examination that includes evaluation of the breasts, abdomen, pelvis, and testes should be done by a physician
- Annual complete blood count to check for anemia should be done